Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A L Barry

Showing results (51-60 of 420) with videos related to

Pageof 42
Sort By:
Antimicrobial Agents and Chemotherapy|April 1, 1988
Antimicrobial activity and disk diffusion susceptibility testing of U-76,253A (R-3746), the active metabolite of the new cephalosporin ester, U-76,252 (CS-807)R N Jones, A L Barry
Journal of Clinical Microbiology|April 1, 1988
Disk diffusion susceptibility testing for LY163892 (KT-3777), a new orally administered 1-carbacephemR N Jones, A L Barry
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 13, 2001
Revision of quality control limits for cefotaxime disk susceptibility testsA L Barry, S D Brown
Antimicrobial Agents and Chemotherapy|October 1, 1988
Antimicrobial activity, spectrum, and recommendations for disk diffusion susceptibility testing of ceftibuten (7432-S; SCH 39720), a new orally administered cephalosporinR N Jones, A L Barry
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 1, 1991
Influence of the test medium on azithromycin and erythromycin regression statisticsA L Barry, P C Fuchs
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1991
Cross-resistance and cross-susceptibility between fluoroquinolone agentsA L Barry, P C Fuchs
Journal of Clinical Microbiology|April 1, 1995
Methods for predicting susceptibility of Streptococcus pneumoniae to cefiximeA L Barry, P C Fuchs
Antimicrobial Agents and Chemotherapy|June 1, 1984
Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populationsA L Barry, R N Jones
Antimicrobial Agents and Chemotherapy|October 1, 1974
Evaluation of two standardized disk methods for testing antimicrobial susceptibility of Pseudomonas aeruginosa and of the EnterobacteriaceaeA L Barry, L J Effinger
Diagnostic Microbiology and Infectious Disease|May 1, 1989
In vitro evaluation of ramoplanin (A16686 or MDL62198). A new depsipeptide complex for potential topical useR N Jones, A L Barry
Pageof 42

Showing results (51-60 of 420) with videos related to

Sort By:
Pageof 42
Antimicrobial Agents and Chemotherapy|April 1, 1988
Antimicrobial activity and disk diffusion susceptibility testing of U-76,253A (R-3746), the active metabolite of the new cephalosporin ester, U-76,252 (CS-807)R N Jones, A L Barry
Journal of Clinical Microbiology|April 1, 1988
Disk diffusion susceptibility testing for LY163892 (KT-3777), a new orally administered 1-carbacephemR N Jones, A L Barry
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 13, 2001
Revision of quality control limits for cefotaxime disk susceptibility testsA L Barry, S D Brown
Antimicrobial Agents and Chemotherapy|October 1, 1988
Antimicrobial activity, spectrum, and recommendations for disk diffusion susceptibility testing of ceftibuten (7432-S; SCH 39720), a new orally administered cephalosporinR N Jones, A L Barry
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 1, 1991
Influence of the test medium on azithromycin and erythromycin regression statisticsA L Barry, P C Fuchs
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1991
Cross-resistance and cross-susceptibility between fluoroquinolone agentsA L Barry, P C Fuchs
Journal of Clinical Microbiology|April 1, 1995
Methods for predicting susceptibility of Streptococcus pneumoniae to cefiximeA L Barry, P C Fuchs
Antimicrobial Agents and Chemotherapy|June 1, 1984
Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populationsA L Barry, R N Jones
Antimicrobial Agents and Chemotherapy|October 1, 1974
Evaluation of two standardized disk methods for testing antimicrobial susceptibility of Pseudomonas aeruginosa and of the EnterobacteriaceaeA L Barry, L J Effinger
Diagnostic Microbiology and Infectious Disease|May 1, 1989
In vitro evaluation of ramoplanin (A16686 or MDL62198). A new depsipeptide complex for potential topical useR N Jones, A L Barry
Pageof 42